NEPAFENAC

This brand name is authorized in Nigeria.

Active ingredients

The drug NEPAFENAC contains one active pharmaceutical ingredient (API):

1	Nepafenac UNII 0J9L7J6V8C - NEPAFENAC
	Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production.
	Read more about Nepafenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5603	Suspension/Drops	Nepafenac Ophthalmic Suspension SUSP_DROPS 0.1%	Ophthalmic Suspension Contains Nepafenac 0.1% w/v, Benzalkonium Chloride Solution BP 0.02% w/v (as Preservative), Sterile Aqueous Vehicle q.s.	28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC10	Nepafenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5603